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Abstract: It has been well established that moderate alcohol consumption inversely correlates with
cardiovascular morbidity and mortality, whereas binge alcohol drinking increases cardiovascular
disease risk. The aim of this study was to assess in vivo the impact of different drinking patterns on
reverse cholesterol transport (RCT); the atheroprotective process leading to the removal of excess
cholesterol from the body. RCT was measured with a standardized, radioisotope-based technique
in three groups of atherosclerosis-prone apolipoprotein E knock out mice: Placebo group, receiving
water, which would mimic the abstainers; moderate group, receiving 0.8 g/kg alcohol/day for
28 days, which would mimic a moderate intake; binge group, receiving 0.8 g/kg alcohol/day for
5 days/week, followed by the administration of 2.8 g/kg alcohol/day for 2 days/week, which would
mimic a heavy intake in a short period. Mice in the binge drinking group displayed an increase
in total cholesterol, high density lipoprotein cholesterol (HDL-c) and non-HDL-c (all p < 0.0001 vs.
placebo), and a significantly reduced elimination of fecal cholesterol. The moderate consumption did
not lead to any changes in circulating lipids, but slightly improved cholesterol mobilization along the
RCT pathway. Overall, our data confirm the importance of considering not only the total amount,
but also the different consumption patterns to define the impact of alcohol on cardiovascular risk.
Keywords: alcohol; binge; reverse cholesterol transport; macrophages
1. Introduction
Alcohol consumption has been extensively studied in relation to its influence on many diseases,
including cardiovascular disease (CVD), infection, cancer, and dementia [1,2]. Observational studies
indicated that high doses of alcohol intake definitely result in organ damage [3,4], whereas moderate
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levels of alcohol consumption are likely to be safe and even beneficial for certain CVD, principally
coronary heart disease [5]. Although the healthy potential of low-level alcohol consumption is still
debated [6], a substantial body of prospective studies analyzed by Castelnuovo et al. in a recent
meta-analysis revealed that light-to-moderate drinking (1–2 drinks per day for women, and 2–4 drinks
per day for men) reduces cardiovascular events in a healthy population, with a 20–30% lower
rate of CVD compared to abstainers [7]. On the contrary, binge drinking (more than 4 drinks
consumed in a short period) has been associated with higher CVD risk compared to moderate
consumption [8]. Based on this observation, the relationship between alcohol dosing and CVD
mortality has been described as a J-shaped curve, with beneficial health effects associated with mild to
moderate consumption, and increased CVD risk associated with higher doses of alcohol [9]. Strikingly,
a very recent meta-analysis revealed the importance of persistent alcohol intake in cardiovascular
risk assessment [10]. Possible mechanisms accounting for alcohol association to cardiovascular health
have been suggested by epidemiological studies demonstrating that moderate alcohol consumption
affects well-known risk factors and markers of CVD, such as inflammatory cytokines, adipokine
levels, and fibrinogen [11]; in particular, modulators of the plasma lipoprotein profile. Moderate
alcohol consumption has been shown to be associated with an increase in high density lipoproteins
(HDL), and apolipoprotein A-I. It has also been associated with a decrease, despite usually small,
in low density lipoproteins (LDL) [12]. In a recent study, Liu et al. showed the differential effect of
alcohol drinking patterns on plasma lipids and atherosclerosis development in mice. In particular, they
demonstrated that daily-moderate alcohol intake improves lipid profile, reducing LDL and increasing
HDL, and decreases atherosclerotic plaque volume. Conversely, weekend binge alcohol intake, despite
increasing HDL, is associated with increased plaque volume and macrophage accumulation in the
neointima [13].
Interestingly, it has been demonstrated that the progression of atherosclerosis inversely correlates
with the efficiency of the HDL-driven Reverse Cholesterol Transport (RCT) pathway, the process
delivering excess cholesterol from peripheral tissues to the liver for the final elimination into the
feces [14]. A pivotal player in RCT is the Scavenger Receptor Class B Type I (SR-BI). Originally
described as a HDL receptor, this cell surface glycoprotein is highly expressed in the liver and
steroidogenic tissues [15], where it promotes the bidirectional exchange of cellular cholesterol to
HDL. Its role in RCT has been definitely demonstrated by Zhang et al., that revealed the positive
regulation of the process in mice overexpressing SR-BI in the liver [16].
The aim of this study was to evaluate the effect of daily-moderate and weekend-binge patterns
of alcohol consumption on the lipid profile and RCT from macrophages in vivo. For these purposes,
athero-prone apolipoprotein E (apoE) knock out mice were administrated with different patterns of
alcohol and the efficiency of whole macrophage-specific RCT was measured with a standardized,
radioisotope-based technique [17]. In addition we investigated alcohol effects on the single steps of RCT
in order to describe novel mechanisms accounting for the association of alcohol with cardiovascular
health. We demonstrated that moderate alcohol consumption slightly impacts macrophage RCT,
whereas binge consumption exerted several pro-atherosclerotic effects, including the increase of total-
and non-HDL cholesterol and the impairment of cholesterol excretion from the body.
2. Materials and Methods
2.1. Animals
Thirty, 12 week-old male C57BL/6 (Envigo) and 29, 10 week old apo E−/−(B6.129P2-apoE
tm1Unc/Crl) mice (Charles River), were housed in a controlled environment and received a standard
chow diet (Mucedola), water ad libitum. The alcohol feeding regimen was selected according to
Liu et al. [13]. Apo E−/− mice were divided into three groups: (1) Placebo (n = 9) receiving
water for 28 days; (2) moderate (n = 10) receiving 0.8 g/kg alcohol/day for 28 days; and (3) binge
(n = 10) receiving 0.8 g/kg alcohol/day for 5 days/week, followed by the administration of 2.8 g/kg
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alcohol/day for 2 days/week. In order to reach the same caloric intake from the treatment in all mice
(0.49 kcal/mice/day), a supplementation of water and cornstarch was provided to the placebo and
moderate groups. The former received 149.8 mg of cornstarch/mouse/day, and the latter 107 mg
of cornstrach/mouse/day. Cornstarch and alcohol were dissolved in water and administrated by
oral gavage.
The study was performed with the approval of the ethical Committee for Animal Experiments of
the University of Parma.
2.2. Biometric and Clinical Analysis
Body weights were measured at baseline and on day 28 of treatment. Total cholesterol, HDL
cholesterol (HDL-c) and triglycerides were quantified through the Aries system for Clinical Chemistry
(ILab International, Milan, Italy), according to manufacturer’s instruction. Total cholesterol was
evaluated by end-point analysis employing a colorimetric reaction (primary λ = 510 nm; secondary
λ = 690 nm) producing a quinoneimine dye that is proportional to cholesterol in the sample. HDL-c was
measured by end-point direct analysis (λ = 620 nm). Triglycerides were measured by end-point direct
analysis employing a colorimetric reaction (primary λ = 510 nm; secondary λ = 690 nm) producing
quinoneimine. Non-HDL-c was calculated as the difference between total and HDL cholesterol.
The activity of plasma alanine aminotransferase (ALT) was determined by a commercial kit
(Sigma-Aldrich, St. Louis, MO, USA), according to manufacturer’s instruction. ALT activity was
determined by a coupled enzyme assay, which results in a colorimetric product (570 nm) proportional
to the pyruvate generated.
2.3. Macrophage RCT in Vivo
Macrophage RCT in vivo was evaluated through a standardised radiolabelled technique, in which
macrophage-derived cholesterol is monitored along the RCT pathways [17,18]. Murine peritoneal
macrophages (MPM) were obtained from C57BL/6 mice injected with 4 g/100 mL thioglycolate, 3 days
before the sacrifice [19]. MPM were grown in suspension, radiolabeled with 5 µCi/µ [3H]-cholesterol,
and enriched with 25 µg/mL of acetylated LDL (AcLDL) for 48 h. On day 26 of treatment with
alcohol, 11.6 × 106 cells/mouse containing 2 × 106 counts per minute [cpm] were i.p. injected into
apo E−/− mice (1 mL/mouse). Blood and feces were collected 24 and 48 h after cell injection. After
the sacrifice (day 28), blood was collected by cardiac puncture into plastic tubes containing EDTA
K3 as anticoagulant. Plasma was obtained by low-speed centrifugation and counted in β-counter.
Livers were excised after perfusion with a saline solution, weighed, and immediately frozen in liquid
nitrogen. Hepatic and fecal sterols were extracted by the Bligh and Dyer method [20], and radioactivity
was counted by liquid scintillation addition.
2.4. Hepatic Lipid Content
Liver samples were mechanically homogenized in H2O, extracted by the Bligh and Dyer method,
and the lipophilic phase was evaporated under a stream of nitrogen. For cholesterol quantification,
the Amplex Red® Cholesterol Assay Kit (Molecular Probes, Eugene, OR, USA) was employed according
to the manufacturer’s instructions. Hepatic triglycerides content was quantified through the Aries
system for Clinical Chemistry (ILab International), as described above. Data were expressed as the
ratio between lipid and protein cellular content, measured by a modified Lowry method [21].
2.5. Evaluation of Cholesterol Efflux Capacity (CEC)
The capacity of mouse plasma to promote cholesterol efflux, the CEC was measured through a
standardized radiolabelled technique [22]. MPM were used as a cell model, in order to follow the
conditions of in vivo RCT. MPM, withdrawn from thioglycolate-treated C57BL/6 mice as described
above, were seeded into 24-wells plate, radiolabelled with 2 µCi/mL [3H]-cholesterol, and enriched
with 25 µg/mL of acLDL for 24 h. Cells were equilibrated in 0.2% albumin-containing RPMI medium.
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Cholesterol efflux was promoted to 0.5% plasma of alcohol-treated apoE−/− mice for 4 h and calculated
as follows: Cpm [3H]-cholesterol in the medium / ([3H]-cholesterol in the medium + [3H]-cholesterol
content in the monolayer) × 100.
2.6. Cholesterol Efflux Assay
MPM withdrawn from thioglycollate-treated C57BL/6 mice, as described above, were seeded
into 24 wells-plates, radiolabelled with 2 µCi/mL [3H]-cholesterol and enriched with 25 µg/mL of
acLDL for 24 h. Cells were equilibrated in 2% FCS-containing RPMI medium and treated with alcohol
or acetaldehyde for 6 h. Cholesterol efflux was promoted to 0.5% control plasma from C57BL6 mouse
for 4 h in the presence of alcohol or acetaldehyde. Cholesterol efflux was calculated as described in the
previous paragraph.
2.7. RNA-Preparation, Reverse Transcription, and Quantitative Real-Time PCR (qPCR)
Total RNA was extracted using TRIzol® Reagent (Life Technologies, Carlsbad, CA, USA),
according to the manufacturer’s instructions. Five-hundred ng of RNA were retro-transcribed using
a iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA). Real Time qPCR was
executed in duplicate in a 96-well PCR plates (Bio-Rad Laboratories, Hercules, CA, U.S.A.) using SSo
Fast Eva Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA). mRNA levels were quantitatively
detected using a CFX96™ Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA,
USA). Relative gene expression was determined through the 2−∆∆Ct method, using the Hprt gene as a
housekeeping gene. Specific primers used to amplify the cDNA fragments were designed through
Beacon Designer Software (Premier Biosoft International, Palo Alto, CA, USA). Scavenger Receptor Class
B type I (Scarb1; sense: 5′ TTCTACTTGTCTGTCTACT 3′; antisense: 5′ ATTGAAGGTGATGTTGAC 3′);
and Hprt (sense: 5′ ACCTGCTGGATTACATTA 3′; antisense: 5′ CTTCAACAATCAAGACATTC 3′).
2.8. Western Blot
Hepatic tissues were lysed in lysis buffer (0.5% Sodium Deoxycolate, 0,1% SDS, 1% Triton X-100,
20mM Tris Base, 150mM NaCl, and 5mM EDTA pH8), supplemented with a Protease Inhibitors
Cocktail (1:100, Life Technologies, Carlsbad, CA, USA). After centrifugation, supernatants were
isolated, sonicated, and protein concentrations were determined through BCA protein assay (Thermo
Scientific, Rockford, IL, USA). Fourty µg of total protein was separated using 10% SDS-polyacrylamide
gel electrophoresis, and then transferred to a PVDF Membrane. Nonspecific labeling was blocked by
adding 5% non-fat-dried milk in TBST for 1 h. Membranes were incubated with primary rabbit anti
mouse SR-BI antibody (Novus Biological, Littleton, CO, USA), overnight at 4 ◦C, and subsequently
with HRP-conjugated donkey anti rabbit secondary antibody (GE Healthcare, Chicago, IL, USA). Bands
were visualized by enhanced chemiluminescence (ECL, Thermo Scientific, Rockford, IL, USA). β-actin
expression was used as control of loading after incubation with HRP-conjugated antibody recognizing
β-actin (Sigma-Aldrich, St. Louis, MO, USA). Images were analyzed using ImageJ software (National
Institute of Mental Health, Bethesda, MA, USA) by two independent blind observers.
2.9. Immunofluorescence Analysis of Liver Cryosections
Liver aliquots were fixed in formalin and embedded in Tissue-Tek OCT (Kaltek, Padua, Italy).
Samples were processed for immunofluorescence microscopy by collecting 7 µm thickness sections
using a cryostat. Sections were fixed with 10% Neutral Buffered Formalin in PBS, and permeabilized
with 0.05% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) in PBS solution. Nonspecific labeling was
blocked by incubating samples with 1% BSA (Sigma-Aldrich, St. Louis, MO, USA), and 0.05% Triton
X-100 in PBS solution. Liver cryosections were incubated with rabbit anti SR-BI (Novus Biological,
Littleton, CO, USA). Sections were incubated for 1 h with goat anti rat AlexaFluor 488 conjugated
antibody (Molecular Probes, Carlsbad, CA, USA), and mouse anti rabbit CruzFluor 594 conjugated
antibody (Santa Cruz Biotechnology, Dallas, TX, USA). Slides were mounted with FluoroshieldTM with
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DAPI histology mounting medium (Sigma-Aldrich, St. Louis, MO, USA), and coverslips were sealed.
Images were acquired with a confocal microscope and SR-BI expression was determined using ImageJ
software by quantifying the immunofluorescence intensity of liver cryosections (red signal) related to
the total number of cells in each section.
2.10. Statistical Analysis
The statistical analyses were performed with Prism 6 software (GraphPad software, San Diego,
CA, USA). The comparisons between placebo, moderate, and binge groups were analyzed by one-way
ANOVA, followed by Tukey’s multiple comparison test between groups. A level of p < 0.05 was
considered significant.
3. Results
3.1. Effect of Moderate and Binge Alcohol Consumption on the Plasma Lipoprotein Profile
Animals receiving moderate and binge alcohol displayed no significant changes in body weight
from baseline to the end of treatment in comparison to control animals (Table 1).
Table 1. Effect of moderate or binge alcohol consumption on body weight, liver function, and plasma
lipid profile.
Placebo Moderate Binge
Body weight at baseline (g) 24.9 ± 1.5 24.3 ± 2.0 24.4 ± 2.3
Body weight on day 28 (g) 25.4 ± 1.8 25.6 ±1.3 24.5 ± 2.0
Liver weight (g) 1.10 ± 0.11 1.14 ± 0.22 1.25 ± 0.21
Hepatic triglycerides (mg/g liver) 9.5 ± 3.8 18.4 ± 4.3 27.5 ± 3.3 §§
ALT (U/L) 2.83 ± 1.25 2.59 ± 1.22 3.18 ± 0.93
Total cholesterol (mg/dL) 328 ± 24 304 ± 39 478 ± 50 §§§§, ****
HDL-c (mg/dL) 11 ± 1 9 ± 1 22 ± 7 §§, ****
Triglycerides (mg/dL) 107 ± 25 151 ± 42 147 ± 26
Non-HDL-c (mg/dL) 316 ± 24 295 ± 39 455 ± 47 §§§§, ****
ALT = alanine aminotransferase; HDL = high density lipoproteins; **** p <0.0001 versus moderate; §§§§ p < 0.0001
versus placebo; §§ p < 0.01 vs. placebo.
At the end of the treatment period we measured liver weight and the activity of plasma ALT
as markers of hepatocellular injury. No significant differences in plasma ALT levels or liver weight
were observed among the groups. All together, these results suggest that animals displayed good
health status throughout the experiment and that neither moderate nor binge intake of alcohol exerted
adverse effects. As expected, alcohol consumption produced a slight increase in triglyceride hepatic
content, more evident in the binge drinking group (Table 1).
Once verified that in our experimental conditions no signs of toxicity were evident, we evaluated
the effect of drinking patterns on plasma lipid levels. We observed that binge, but not moderate
alcohol consumption, significantly affected lipidemia. In detail, plasma total cholesterol significantly
increased in mice receiving binge as compared to placebo (+45%), and moderate (+56%) groups. Mice
receiving binge alcohol also showed higher levels of HDL-c compared to placebo (+98%), and moderate
(+136%) groups. Interestingly, binge alcohol consumption also significantly increased non-HDL plasma
cholesterol in comparison with placebo (+44%), and moderate (+54%) groups. Moderate and binge
groups showed a tendency to higher triglycerides plasma levels compared to the placebo group, even
though no statistically significant differences were reached (Table 1).
3.2. Effecst of Moderate and Binge Alcohol Consumption on the Reverse Cholesterol Transport in Vivo
The impact of alcohol on the distribution of 3H-cholesterol along the RCT pathway was evaluated
by measuring radioactivity content in plasma, liver, and feces. No significant differences among
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the three groups were evident in the amount of radioactivity of plasma 48 h after the injection of
radiolabeled cholesterol (Figure 1A).
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Figure 1. Effects of moderate and binge alcohol consumption on macrophage reverse cholesterol
transport (RCT) in vivo. Apo E−/− (B6.129P2-apoEtm1Unc/Crl) mice were treated with alcohol for 28
days as described in the Methods Section. On day 26 of treatment, animals were intraperitoneally
injected with [3H]-cholesterol loaded murine peritoneal macrophages. After 48 h, mice were sacrificed
and macrophage-derived [3H]-cholesterol distribution was quantified in plasma (A), liver (B), and feces
(C). Total RCT was calculated as the sum of radioactivity detected in plasma, liver, and feces and
expressed as percentage of [3H] dose injected (D). Results are expressed as mean ± SD (n = 9–10 mice
per group) and were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test
among groups.
The amount of radioactivity in the liver was significantly higher in the moderate and binge
groups compared to placebo (p < 0.001 and p < 0.01 respectively; Figure 1B), whereas the binge group
excreted significantly less 3H-cholesterol at 48 h compared to the placebo (p < 0.05; Figure 1C). Overall,
the removal of radioactivity from macrophages along the RCT pathway was higher, despite not
statistically significant, in animals treated with a moderate dose of alcohol (Figure 1D), suggesting a
slight promotion of the process.
3.3. Hepatic Cholesterol Content of Mice undergoing Moderate and Binge Alcohol Consumption
In order to investigate if the increased recovery of radioactive cholesterol associated with alcohol
consumption was due to an accumulation of choleste ol n the liver, th t t l amount of epatic
ch lesterol content was qu tified. Moderate, as well as binge alcohol intake, did not influ nce
the amount of total hepatic cholesterol (Figur 2), sugge ting th t the observ d increase in hepatic
cholesterol involved only the macrophage-derived cholesterol.
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Figure 2. Hepatic cholesterol content in mice undergoing moderate and binge alcohol consumption.
Apo E−/−(B6.129P2-apoEtm1Unc/Crl) mice were treated with alcohol for 28 days as described in the
Methods Section. On day 28 of treatment, mice were sacrificed and the livers were collected after
perfusion with a saline solution. Cholesterol was extracted according to Bligh and Dyer method,
and successively quantified using a fluorimetric assay as described in the Methods Section. Data are
presented as µg of cholesterol per mg of tissue proteins (mean± SEM; n = 9–10 mice per group). Results
were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test among groups.
3.4. Effect of Moderate and Binge Alcohol Consumption on the First Step of RCT
To assess whether the increased radioactivity in the liver was caused by a promotion of the first
step of RCT, cholesterol efflux from macrophages, we followed two different approaches. In the former,
we investigated the impact of different alcohol consumption patterns on the capacity of circulating HDL
to promote cell cholesterol efflux. For this purpose, we incubated cholesterol-loaded macrophages with
the plasma of mice consuming placebo, moderate, or binge alcohol. As shown in Figure 3, no difference
in HDL function was observed, thus ruling out our hypothesis.
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Figure 3. Effect of moderate and binge alcohol consumption on plasma cholesterol efflux capacity
CEC. Murine peritoneal macrophages (MPM) were cholesterol enriched with 25 mg/mL acetylated
LDL (AcLDL) and radiolabeled with [3H]-cholesterol 2 µCi/mL. After an equilibration period of
18 h, cells were exposed to 0.5% plasma from mice treated with placebo for 5 h, moderate or binge
alcohol as described in the Methods Section. Efflux is expressed as cpm in medium/cpm of time zero
× 100 (values are the mean of a triplicate). Data are expressed as mean ± SEM (n = 9–10 mice per
group). Results were analyzed using one-way ANOVA followed by Tukey’s multiple comparison test
among groups.
In the latter, we evaluated the direct effect of alcohol and its metabolite acetaldehyde on cholesterol
efflux from macrophages. MPM were treated with two different concentrations of alcohol (20 mM and
60 mM) corresponding to the plasma concentration after a moderate and a heavy alcohol consumption
in mice [13]. Similarly, acetaldehyde concentrations (15 µM and 45 µM) were selected in a range
detected after alcohol intake in mice [23,24]. As shown in Figure 4, neither alcohol nor acetaldehyde
affected cell capacity to eliminate cholesterol to extracellular acceptors. Therefore, also the involvement
of increased macrophage efflux was not confirmed.
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Figure 4. Effect of alcohol (Eth) and acetaldehyde (Ace) on cholesterol efflux from macrophages. MPM
were cholesterol enriched with 25 µg/mL AcLDL and radiolabeled with [3H]-cholesterol 2 µCi/mL.
Cells were equilibrated in 2% FCS-containing medium and treated with alcohol or acetaldehyde.
Cholesterol efflux was promoted to 0.5% mouse plasma for 4 h in presence of acetaldehyde and alcohol
as described in the Methods Section. Efflux is expressed as cpm in medium/cpm of time zero × 100
(values are mean of three triplicate). Data are expressed as mean ± SEM. Results were analyzed using
one-way ANOVA followed by Tukey’s multiple comparison test among groups.
3.5. Effect of Moderate and Binge Alcohol Consumption on Hepatic Expression of SR-BI
To investigate whether the increased radioactivity in the liver observed in moderate and binge
groups was caused by a higher cholesterol uptake mediated by hepatic SR-BI, we quantified both
gene and protein expression. As shown in Fig re 5, Scarb1 gene expression was higher in the binge
group compared to placebo (p < 0.05), whereas no difference was observed between moderate and
placebo grou s.
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Figure 5. Effect of moderate and binge alcohol consumption on hepatic Scarb1 gene expression. RNA
was isolated from liver, as described in the Methods Section. Scarb1 mRNA levels were determined
by quantitative RT-PCR. Hprt was used as housekeeping gene for the normalization of Scarb1 gene
expression. Data are expressed as mean ± SD (n = 3–4 per group). Results were analyzed using
one-way ANOVA followed by Tukey’s multiple comparison test among groups.
SR-BI protein expr ssion in liver was evaluated through western blotting and confocal
immunofluorescence microscopy. None of these techniques showed statistically significant differences
in hepatic SR-BI protein expression, although a tendency to increased expression was observed both
in oderate and binge groups compared to placebo (Figure 6). This evidence could, at least in part,
explain the observed increase in macrophage-derived cholesterol in the liver.
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4. Discussion
It is well accepted that, in addition to the amount consumed, the drinking pattern is a relevant
factor influencing the impact of alcohol on CVD [8,10]. Whereas the intake of daily, moderate dose
of alcohol is associated with lower incidence of cardiovascular mortality, the episodic intake of high
amounts of alcohol concentrated over few hours causes a higher risk of acute events [25]. In the present
paper we described the impact of different drinking patterns on the atheroprotective process of RCT in
atherogenic prone ApoE knock out mice. Although these animals exhibited higher plasma cholesterol
levels and spontaneous development of atherosclerotic lesions, the absence of systemic ApoE did not
influence the efficiency of macrophages RCT [19]. The strain of animals was chosen in accordance with
the work of Liu et al., who previously demonstrated that moderate alcohol consumption promotes the
regression of atherosclerotic lesions, whereas binge intake caused their exacerbation [13]. The aim of
our study was to investigate whether the different alcohol pattern could differently affect the specific
removal of excess cholesterol from macrophages. Since our focus was to unravel alcohol effect on the
efficiency of macrophage RCT rather than on the development of atheroma lesion, animals were fed a
standard chow diet. Moreover, differently from the work by Liu et al., in our study the binge group
received a moderate intake of alcohol for 5 days/week, overall mimicking a heavy consumption. It is
important to underline that the selected treatment protocol did not negatively affect animal health, as
indicated by the lack of differences in body and liver weights among groups, as well as the normal
level of hepatic transaminase.
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Mice receiving binge drinking displayed significant modifications of their plasma lipoprotein
profile, with an increase in total cholesterol, HDL-c and non-HDL-c. These results were fully consistent
with the effects of alcohol on lipoprotein pattern observed by Liu and colleagues [13]. Conversely,
the moderate consumption did not produce significant changes in circulating lipids.
Under experimental conditions, the impact of alcohol consumption on the extent of macrophage
RCT was modest. Interestingly, moderate and binge intake resulted in increased mobilization of
cholesterol from macrophages to the liver. This result could be explained by the improvement of
the first (cholesterol efflux from macrophages) or the second (hepatic cholesterol uptake) step of
the process. To address the first question, we tested: (i) The capacity of alcohol and its primary
metabolite acetaldehyde to directly affect cell cholesterol release; and (ii) the capacity of plasma from
mice treated with placebo, moderate, or binge alcohol to promote cell cholesterol efflux. In fact, it is
well known that cholesterol efflux from macrophages in vivo is influenced by (i) the capacity of cells
to release cholesterol to extracellular acceptors, and (ii) the capacity of circulating lipoproteins to
capture cholesterol from cells [22]. The first mechanism was supported by previous publications
reporting alcohol capacity to affect cell cholesterol efflux. In a study performed in fibroblasts, cell
exposition to concentrations of alcohol as found in plasma of heavy drinkers produced a reduction
of cholesterol release to both apolipoprotein A-I and HDL [26]. Conversely, alcohol caused the
increase of the expression and function of ATP Binding Cassette (ABC)A1 and ABCG1 transporters
in astrocytes [27,28]. However, in our cultured, cholesterol-loaded macrophages, where ABCA1
and ABCG1 represent the key drivers of cholesterol efflux [29], neither alcohol nor acetaldehyde
significantly affected cholesterol release. Thus, we could rule out the involvement of these transporters
in the promotion of cholesterol mobilization from macrophages to the liver. Also, the second
mechanism could be excluded, since plasmas from all groups displayed the same ability to take
cholesterol from cholesterol-enriched macrophages.
To evaluate whether the increased appearance of radioactive cholesterol in the liver of
alcohol-treated mice was related to an ameliorated hepatic uptake, we measured gene and protein
expression of SR-BI, a well characterized HDL receptor [30]. Consistent with a recently published
report [31], we observed that alcohol intake increased SR-BI gene expression compared to placebo.
In particular, moderate consumption was related to the highest expression of SR-BI protein, an
observation that was fully consistent with the trend of RCT. It is important to underline that this effect
was not associated with a general raise of hepatic cholesterol mass, thus indicating that the specific
delivery of macrophage-derived cholesterol was improved by alcohol.
Mice receiving binge alcohol presented similar amount of radioactive cholesterol in plasma
and liver compared to the moderate drinking group, but showed a significant impairment of
cholesterol elimination through the feces. This result indicated an additional deleterious effect of binge
consumption, beyond the already reported alteration of lipoprotein profile. Moreover, it is worth to
underline that the binge-driven raise of HDL cannot be interpreted as a beneficial effect, because these
lipoproteins do not promote higher cholesterol efflux.
5. Conclusions
In conclusion, in this study moderate alcohol consumption in mice was associated with little
impact on macrophage RCT, and no effect on lipoprotein profile. Interestingly, binge consumption,
in the absence of hepatic toxic features, revealed several pro-atherosclerotic effects, including the
increase of total and non-HDL cholesterol, the formation of dysfunctional HDL and the impairment
of cholesterol excretion from the body. These data further confirm the importance of considering,
at educational and clinical level, both the total amount and the different consumption patterns on the
impact of alcohol on cardiovascular risk.
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